A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma
Clinical trial NCT05595473 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05595473
- Sponsor
- Rznomics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2029-03-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.